Biotech Showcase™ 2017: What's ahead with the new Trump administration?

January 18, 2017
It’s no secret that the life sciences industry has had some challenging moments with lawmakers in recent years. And despite efforts by the White House, Congress, FDA, and other regulatory agencies, in most cases the law continues to lag behind the industry’s pace of innovation. So, how will the Trump Administration address the industry’s challenges?
Previous Video
Digital Medicine Showcase 2017: Fireside Chat with Bryan Roberts
Digital Medicine Showcase 2017: Fireside Chat with Bryan Roberts

Gain insights from one of the industry’s most successful investors, featured on the Forbes Midas list eight...

Next Video
Biotech Showcase™ 2017: The financial continuum and value creation
Biotech Showcase™ 2017: The financial continuum and value creation

Biotech financial markets were buffeted by the winds of macro-economic events in 2016 ranging from the Brex...